$CACI

Contract awards totaled $4.8 billion for CACI; about 61% was new business.

CACI reported $2.47B revenue and $130.4M net income for Q1 FY2027, up 8.2% and 4.5% YoY respectively. The company secured $4.8B in contract awards, with 61% being new business. CACI raised its FY2027 guidance for revenue and earnings, citing strong backlog and pipeline. Key contracts include a $1.5B award for USCENTCOM and a $1.2B task order for USASOC.

Original reporting
Published Oct 21, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CACI
Bullish
high confidence
Mentioned
$CACI
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CACIBullishHigh
01

Why it matters

The earnings beat and guidance raise provide a catalyst for short-term price appreciation.

02

Market read

First earnings release of FY2027 with significant guidance uplift and $4.8B in contract awards, likely to move the stock.

03

What to watch

Potential execution risk on large contract backlog and macro fiscal pressures.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

CACI International Inc. is a U.S. defense and IT services contractor. The release details Q1 FY2027 financials and new contract awards.

Company-level read

Ticker impact

$CACIBullishHigh confidence
Context

CACI reported Q1 FY2027 results with revenue up 8.2% and raised FY2027 revenue and earnings guidance.

Expected impact

likely upward pressure as market prices in higher revenue and earnings outlook

Evidence & confidence

The company disclosed higher guidance and $4.8B of new contract awards, providing fresh material that can move the stock.

Market effects

Strengthens defense and government services sector outlook.

Positive for U.S. defense contractors.

Limited to defense and federal contract markets.

Counterpoint

If guidance is overly optimistic, the stock could face disappointment on actual performance.

Key entities

  • John Mengucci

    President and CEO of CACI, quoted on results and outlook.

Related articles

$CACIHighAI 8/10

CACI International Inc (CACI) (Q1 2027) Earnings Call Highlights: Record

CACI International reported Q1 2027 earnings with 2.1% organic growth, citing supply chain constraints and budget uncertainty. CEO John Mengucci highlighted a clear strategy and disciplined execution. The company expects stronger growth in the second half, supported by funded backlog growth and recent awards. Integration of acquisitions like ARKA is affecting revenue recognition timing. CACI manages 1,900 programs with varying margins and focuses on long-term investments.

$CACIHighAI 8/10

CACI (CACI) Q1 2027 Earnings Call Transcript

CACI reported Q1 2027 revenue growth of 8%, EBITDA margin of 13.3%, and adjusted EPS increase of 12%. The company generated $133M in free cash flow and won $4.8B in awards. CACI raised its full-year guidance, citing strong demand for its technology, particularly in electronic warfare and space domains. The company is investing in manufacturing capacity to meet demand.

$CACIMed

What CACI International (CACI) Said on Its Q1 Earnings Call

CACI International reported Q1 earnings, highlighting new contracts like Apollo and SOFETOPS 2, and demand for electronic warfare and counter-UAS systems. The company expects to complete Space Development Agency Tranche 1 deliveries this year. CACI opened a new manufacturing center and plans to reduce leverage to 3x by March 2027. Management expressed confidence in the outlook despite a sluggish funding environment.

$CACIHighAI 8/10

CACI Q1 FY27 slides: margin expansion drives guidance raise

CACI International reported Q1 FY27 revenue of $2.47B, up 8.2% YoY but below estimates. EBITDA margin expanded to 13.3%, and EPS beat estimates by 17%. The company raised its FY27 guidance, citing strong profitability and margin expansion. Shares rose 3% premarket. According to CACI, the new guidance reflects improved business visibility and strategic investments.

$CACIMedAI 8/10

CACI (NYSE:CACI) misses Q3 CY2026 sales expectations

CACI reported Q3 CY2026 revenue of $2.47B, missing estimates by 1.4% but beating on adjusted EPS ($7.66 vs $6.60). Adjusted EBITDA also exceeded expectations. The company raised full-year revenue and EPS guidance. Operating margin was steady, but free cash flow margin declined. Backlog remained unchanged at $34B.